Impact of
Journal
The Journal of pharmacology and experimental therapeutics
ISSN: 1521-0103
Titre abrégé: J Pharmacol Exp Ther
Pays: United States
ID NLM: 0376362
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
received:
04
02
2022
accepted:
24
06
2022
pubmed:
8
7
2022
medline:
30
8
2022
entrez:
7
7
2022
Statut:
ppublish
Résumé
6-Mercaptopurine (6-MP) is used extensively in the treatment of acute lymphoblastic leukemia (ALL) and inflammatory bowel diseases. Our laboratory determined previously, using a recombinant HEK293 cell model, that the
Identifiants
pubmed: 35798387
pii: jpet.122.001155
doi: 10.1124/jpet.122.001155
doi:
Substances chimiques
Amino Acid Transport Systems
0
SLC43A3 protein, human
0
Mercaptopurine
E7WED276I5
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
335-345Subventions
Organisme : CIHR
ID : 168913
Pays : Canada
Informations de copyright
Copyright © 2022 by The American Society for Pharmacology and Experimental Therapeutics.